Point of Care Molecular Diagnostics Device Market

1. Point of Care Molecular Diagnostics Device Market was valued at USD635.5 million in 2017 and is estimated to grow at a CAGR of 15.5% from 2017 to 2024. Point of Care Molecular Diagnostics Device Market Point of Care Molecular Diagnostics Device Market1 A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system. It has a rapid turnaround time (approximately 15 min) and provides actionable information that can lead to better patient management. Some of the key market drivers include the increasing technological advancements, ability to diagnose infectious diseases at sites with a limited infrastructure, availability of clinical evidence for the safety and efficacy procedures, patients awareness about better healthcare options and readiness for rising healthcare expenditures, changing technology and innovation, changing demographics and lifestyles leading to an increased prevalence of peripheral vascular diseases, adoption of new products, rising demand for advanced medical instruments, geriatric population. Point of Care Molecular Diagnostics Device Market is segmented by product & service, technology, application, end user, and region. Point of Care Molecular Diagnostics Device Market has the largest usage in Physician Offices, Hospital Emergency Departments & Intensive Care Units, and Research Institutes

2. Geographically, global point of care molecular diagnostics device market is classified into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). In 2018, North America is anticipated to have the largest share in the global adhesion barrier market. The largest ratio of the North American market can mostly be attributed to the high prevalence of technologically advanced medical framework, sophisticated insurance & co-payment system & high R&D investment by governments and private funding organizations for the development of POC MDx tests are major factors responsible for the region’s dominant market position. Availability of clinical evidence for the safety and efficacy of point of care molecular diagnostics procedures, transmuting technology and innovation. Asia Pacific market is expected to grow at the fastest rate during the forecast period owing to the increasing demand for POC test. Many minuscule players are looking forward to investment in the Asia Pacific market due to sizable patient pool and incremental utilization of global adhesion barrier market devices. The key players in the Point of Care Molecular Diagnostics Device Market include Roche Diagnostics (Switzerland), Biomerieux (France), Danaher (US), Abbott Laboratories (US), Quidel (US) and Meridian Bioscience (US). The years that have been considered for the study are: • Base year – 2016 • Estimated year – 2017 • Forecast period – 2017 to 2024 Target Audience: • POC Molecular Diagnostics Manufacturers • Physicians • Research Institutes • Diagnostics Suppliers • Market Research and Consulting Firms • Regulatory Bodies • Venture Capitalists Point of Care Molecular Diagnostics Device Market- Key Segment:

3. Fore molecular-diagnostics-device-market/10995/ More Info Visit: https://www.maximizemarketresearch.com/market-report/point-of-care- • Point of Care Molecular Diagnostics Device Market, By Product & Service: o Assays & Kits o Instruments/Analysers o Services & Software •Point of Care Molecular Diagnostics Device Market, By Application: o Respiratory diseases o STDs o HAIs o Oncology o Hepatitis •Point of Care Molecular Diagnostics Device Market, By Technology: o RT-PCR o INAAT o Others Technologies • Point of Care Molecular Diagnostics Device Market, By End User: o Physician Offices o Hospital Emergency Departments & Intensive Care Units o Research Institutes o Other End User Company Profiles:

4. • Abacus Diagnostica • Advanced Liquid Logic (Illumina) • Ahram Biosystems • Akonni Biosystems • Alere (Abbott) • Amplino • Analytik Jena • Aquila Diagnostic Systems • Atlas Genetics • Axxin • Becton, Dickinson & Co. (BD) • Biocartis • Biomeme • bioMérieux • Canon BioMedical • Cepheid • Coris BioConcept • Coyote Bioscience • Curetis • DestiNA Genomics • Diagnostics For All • Diagnostics for the Real World • DiaSorin • DiAssess • DNA Electronics • DxNA Point of Care Molecular Diagnostics Device Market, By Region North America

5. • U.S • Canada Europe • Germany • France • UK • Italy • Spain • Russia • Rest of Europe Asia Pacific • Japan • China • India • South Korea • Australia • Rest of Asia Pacific Rest of the World (ROW): • Middle-East • Africa • Latin America This Report Is Submitted By Maximize Market Research Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

6. About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact info: Name: Lumawant Godage Organization: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: sales@maximizemarketresearch.com Address: Maharashtra 411051, India.